JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area mapk jnk'

Search results for: 'research area mapk jnk'

A1337 U0126-EtOH

10 Citation

Target: MEK

Summary: MEK1/2 inhibitor

≥21.33 mg/mL
A3018 Trametinib (GSK1120212)

7 Citation

Target: MEK

Summary: MEK1 and MEK2 inhibitor, potent and selective

insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL
A3016 PLX-4720

1 Citation

Target: Raf

Summary: BRAF kinase inhibitor

≥20.69 mg/mL
A5801 BIX 02189

Target: MEK|ERK

Summary: Selective MEK5 inhibitor

≥22.05 mg/mL
A3004 Vemurafenib (PLX4032, RG7204)

9 Citation

Target: Raf

Summary: BRAF kinase inhibitor

≥24.5 mg/mL
B1285 SB 203580 hydrochloride

Target: p38

Summary: Specific p38-MAPKs inhibitor

insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL
A8313 RAF265

Target: Raf|VEGFR

Summary: Multiple intracellular kinases inhibitor

≥25.9 mg/mL
A8245 Sorafenib Tosylate

1 Citation

Target: Raf|VEGFR

Summary: Raf kinases and tyrosine kinases inhibitor

≥31.85 mg/mL
A3009 Sorafenib

2 Citation

Target: Raf|VEGFR

Summary: Raf kinases and tyrosine kinases inhibitor

≥23.25 mg/mL
B6674 Anisomycin

Target: p38|JNK|SAPK

Summary: JNK agonist, potent and specific

≥26.5 mg/mL